PUBLISHER: KBV Research | PRODUCT CODE: 1093178
PUBLISHER: KBV Research | PRODUCT CODE: 1093178
LAMEA Analgesics Market Size, Share & Industry Trends Analysis Report By Type (Non-opioids and Opioids), By Route of Administration (Oral, Transdermal, Intravenous, Topical, and Rectal), By Country and Growth Forecast, 2022 - 2028
The Latin America, Middle East and Africa Analgesics Market would witness market growth of 8.8% CAGR during the forecast period (2022-2028).
Analgesics have observed a large increase in the demand over the years due to the rising therapeutic benefits they provide, as well as effective and quick pain relief. The analgesics market has also benefited from the introduction of novel medications and increased knowledge of these treatment options. Furthermore, a surge in the incidence of recurring aches and pains as a result of a rise in the frequency of cancer, arthritis, cardiovascular disease, and other chronic and acute disorders has boosted analgesic demand. The rising prevalence of pain worldwide, the growth in effective treatment choices, and the growing adoption of analgesics by a wider target audience are all factors that are positively impacting the analgesics market.
The United Arab Emirates (UAE) has one of the world's fastest-growing economies, resulting in an increase in non-communicable diseases including cancer. Despite early detection and screening measures that seems to fall short of the target population's coverage goal, the number of detected cases along with deaths in the UAE has been increasing over time. In a single article, the NCBI, or National Center for Biotechnology Information, highlighted key features of a proposed UAE national cancer management plan. The concept is currently being developed and has not yet been formally adopted. For a thorough and effective management strategy, a reliable cancer registry, accurate data, and periodic monitoring and evaluation are all essential. In addition, the UAE's cancer management strategy is being established in accordance with EMRO and WHO recommendations, with specific goals and objectives in mind. The objectives are to combat cancer, reduce its occurrence, regulate mortality, and improve the outcomes and quality of life of cancer patients. Prevention, early detection, quick diagnosis, continuity of care, treatment facilitation, performance evaluation, and research are primary objectives.
The Brazil market dominated the LAMEA Analgesics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $999.8 Million by 2028. The Argentina market is estimated to grow at a CAGR of 9.4% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 8.5% during (2022 - 2028).
Based on Type, the market is segmented into Non-opioids and Opioids. Based on Route of Administration, the market is segmented into Oral, Transdermal, Intravenous, Topical, and Rectal. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Reckitt Benckiser Group PLC, Abbott Laboratories, Johnson & Johnson, Bayer AG, Endo International PLC, GlaxoSmithKline PLC, Pfizer, Inc., Sanofi S.A., and Eli Lilly And Company.
Scope of the Study
Market Segments covered in the Report:
By Type
- Non-opioids
- Opioids
By Route of Administration
- Oral
- Transdermal
- Intravenous
- Topical
- Rectal
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- AbbVie, Inc.
- Reckitt Benckiser Group PLC
- Abbott Laboratories
- Johnson & Johnson
- Bayer AG
- Endo International PLC
- GlaxoSmithKline PLC
- Pfizer, Inc.
- Sanofi S.A.
- Eli Lilly And Company
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Analgesics Market, by Type
- 1.4.2 LAMEA Analgesics Market, by Route of Administration
- 1.4.3 LAMEA Analgesics Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Strategies deployed in Analgesics Market
Chapter 4. LAMEA Analgesics Market by Type
- 4.1 LAMEA Macro processing Market by Country
- 4.2 LAMEA Micro processing Market by Country
Chapter 5. LAMEA Analgesics Market by Route of Administration
- 5.1 LAMEA Oral Market by Country
- 5.2 LAMEA Transdermal Market by Country
- 5.3 LAMEA Intravenous Market by Country
- 5.4 LAMEA Topical Market by Country
- 5.5 LAMEA Rectal Market by Country
Chapter 6. LAMEA Analgesics Market by Country
- 6.1 Brazil Analgesics Market
- 6.1.1 Brazil Analgesics Market by Type
- 6.1.2 Brazil Analgesics Market by Route of Administration
- 6.2 Argentina Analgesics Market
- 6.2.1 Argentina Analgesics Market by Type
- 6.2.2 Argentina Analgesics Market by Route of Administration
- 6.3 UAE Analgesics Market
- 6.3.1 UAE Analgesics Market by Type
- 6.3.2 UAE Analgesics Market by Route of Administration
- 6.4 Saudi Arabia Analgesics Market
- 6.4.1 Saudi Arabia Analgesics Market by Type
- 6.4.2 Saudi Arabia Analgesics Market by Route of Administration
- 6.5 South Africa Analgesics Market
- 6.5.1 South Africa Analgesics Market by Type
- 6.5.2 South Africa Analgesics Market by Route of Administration
- 6.6 Nigeria Analgesics Market
- 6.6.1 Nigeria Analgesics Market by Type
- 6.6.2 Nigeria Analgesics Market by Route of Administration
- 6.7 Rest of LAMEA Analgesics Market
- 6.7.1 Rest of LAMEA Analgesics Market by Type
- 6.7.2 Rest of LAMEA Analgesics Market by Route of Administration
Chapter 7. Company Profiles
- 7.1 AbbVie, Inc. (Allergan PLC)
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Approvals and Trials:
- 7.2 Reckitt Benckiser Group PLC
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expenses
- 7.2.5 Recent strategies and developments:
- 7.2.5.1 Product Launches and Product Expansions:
- 7.3 Abbott Laboratories
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 Recent strategies and developments:
- 7.3.5.1 Product Launches and Product Expansions:
- 7.3.5.2 Approvals and Trials:
- 7.4 Johnson & Johnson
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental &Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.5 Bayer AG
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
- 7.5.5.1 Product Launches and Product Expansions:
- 7.6 Endo International PLC
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expense
- 7.7 GlaxoSmithKline PLC
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expense
- 7.7.5 Recent strategies and developments:
- 7.7.5.1 Partnerships, Collaborations, and Agreements:
- 7.7.5.2 Geographical Expansions:
- 7.8 Pfizer, Inc.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional & Segmental Analysis
- 7.8.4 Research & Development Expense
- 7.8.5 Recent strategies and developments:
- 7.8.5.1 Partnerships, Collaborations, and Agreements:
- 7.9 Sanofi S.A.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expense
- 7.10. Eli Lilly And Company
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Regional Analysis
- 7.10.4 Research & Development Expenses
- 7.10.5 Recent strategies and developments:
- 7.10.5.1 Partnerships, Collaborations, and Agreements:
- 7.10.5.2 Geographical Expansions:
LIST OF TABLES
- TABLE 1 LAMEA Analgesics Market, 2018 - 2021, USD Million
- TABLE 2 LAMEA Analgesics Market, 2022 - 2028, USD Million
- TABLE 3 LAMEA Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 4 LAMEA Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 5 LAMEA Macro processing Market by Country, 2018 - 2021, USD Million
- TABLE 6 LAMEA Macro processing Market by Country, 2022 - 2028, USD Million
- TABLE 7 LAMEA Micro processing Market by Country, 2018 - 2021, USD Million
- TABLE 8 LAMEA Micro processing Market by Country, 2022 - 2028, USD Million
- TABLE 9 LAMEA Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 10 LAMEA Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 11 LAMEA Oral Market by Country, 2018 - 2021, USD Million
- TABLE 12 LAMEA Oral Market by Country, 2022 - 2028, USD Million
- TABLE 13 LAMEA Transdermal Market by Country, 2018 - 2021, USD Million
- TABLE 14 LAMEA Transdermal Market by Country, 2022 - 2028, USD Million
- TABLE 15 LAMEA Intravenous Market by Country, 2018 - 2021, USD Million
- TABLE 16 LAMEA Intravenous Market by Country, 2022 - 2028, USD Million
- TABLE 17 LAMEA Topical Market by Country, 2018 - 2021, USD Million
- TABLE 18 LAMEA Topical Market by Country, 2022 - 2028, USD Million
- TABLE 19 LAMEA Rectal Market by Country, 2018 - 2021, USD Million
- TABLE 20 LAMEA Rectal Market by Country, 2022 - 2028, USD Million
- TABLE 21 LAMEA Analgesics Market by Country, 2018 - 2021, USD Million
- TABLE 22 LAMEA Analgesics Market by Country, 2022 - 2028, USD Million
- TABLE 23 Brazil Analgesics Market, 2018 - 2021, USD Million
- TABLE 24 Brazil Analgesics Market, 2022 - 2028, USD Million
- TABLE 25 Brazil Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 26 Brazil Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 27 Brazil Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 28 Brazil Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 29 Argentina Analgesics Market, 2018 - 2021, USD Million
- TABLE 30 Argentina Analgesics Market, 2022 - 2028, USD Million
- TABLE 31 Argentina Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 32 Argentina Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 33 Argentina Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 34 Argentina Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 35 UAE Analgesics Market, 2018 - 2021, USD Million
- TABLE 36 UAE Analgesics Market, 2022 - 2028, USD Million
- TABLE 37 UAE Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 38 UAE Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 39 UAE Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 40 UAE Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 41 Saudi Arabia Analgesics Market, 2018 - 2021, USD Million
- TABLE 42 Saudi Arabia Analgesics Market, 2022 - 2028, USD Million
- TABLE 43 Saudi Arabia Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 44 Saudi Arabia Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 45 Saudi Arabia Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 46 Saudi Arabia Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 47 South Africa Analgesics Market, 2018 - 2021, USD Million
- TABLE 48 South Africa Analgesics Market, 2022 - 2028, USD Million
- TABLE 49 South Africa Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 50 South Africa Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 51 South Africa Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 52 South Africa Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 53 Nigeria Analgesics Market, 2018 - 2021, USD Million
- TABLE 54 Nigeria Analgesics Market, 2022 - 2028, USD Million
- TABLE 55 Nigeria Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 56 Nigeria Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 57 Nigeria Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 58 Nigeria Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 59 Rest of LAMEA Analgesics Market, 2018 - 2021, USD Million
- TABLE 60 Rest of LAMEA Analgesics Market, 2022 - 2028, USD Million
- TABLE 61 Rest of LAMEA Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 62 Rest of LAMEA Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 63 Rest of LAMEA Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 64 Rest of LAMEA Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 65 Key information - AbbVie, Inc.
- TABLE 66 Key information - Reckitt Benckiser Group PLC
- TABLE 67 Key Information - Abbott Laboratories
- TABLE 68 Key information - Johnson & Johnson
- TABLE 69 Key Information - Bayer AG
- TABLE 70 Key Information - Endo International PLC
- TABLE 71 Key Information - GlaxoSmithKline PLC
- TABLE 72 Key Information - Pfizer, Inc.
- TABLE 73 Key Information - Sanofi S.A.
- TABLE 74 Key Information - Eli Lilly And Company
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Recent strategies and developments: Abbott Laboratories
- FIG 3 Recent strategies and developments: Eli Lilly And Company
